Canaccord Genuity Cuts Price Target on Abaxis (ABAX) Following Veterinarian Survey

July 23, 2015 9:37 AM

Canaccord Genuity reiterated a Buy rating on Abaxis Inc. (NASDAQ: ABAX), and cut the price target to $62.00 (from $68.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found